Mufg Securities Americas Inc. Acquires Shares of 10,593 Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Mufg Securities Americas Inc. acquired a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 10,593 shares of the pharmacy operator’s stock, valued at approximately $99,000.

A number of other hedge funds have also added to or reduced their stakes in WBA. Man Group plc grew its position in shares of Walgreens Boots Alliance by 53.3% in the 4th quarter. Man Group plc now owns 1,855,898 shares of the pharmacy operator’s stock worth $17,316,000 after buying an additional 645,358 shares during the period. Nissay Asset Management Corp Japan ADV grew its position in shares of Walgreens Boots Alliance by 3.0% in the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 107,120 shares of the pharmacy operator’s stock worth $1,030,000 after buying an additional 3,157 shares during the period. NorthRock Partners LLC grew its position in shares of Walgreens Boots Alliance by 180.3% in the 4th quarter. NorthRock Partners LLC now owns 30,410 shares of the pharmacy operator’s stock worth $284,000 after buying an additional 19,559 shares during the period. Occudo Quantitative Strategies LP purchased a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth about $242,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Walgreens Boots Alliance by 26.7% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 274,773 shares of the pharmacy operator’s stock worth $2,564,000 after buying an additional 57,951 shares during the period. 58.59% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina acquired 832,258 shares of the stock in a transaction dated Sunday, April 27th. The shares were purchased at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the purchase, the chairman now directly owns 145,621,079 shares of the company’s stock, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 17.50% of the company’s stock.

Walgreens Boots Alliance Price Performance

WBA opened at $11.29 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The stock has a market capitalization of $9.76 billion, a P/E ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.77. The company’s 50-day simple moving average is $11.02 and its two-hundred day simple moving average is $10.36. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $18.17.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.10. The business had revenue of $38.59 billion for the quarter, compared to analysts’ expectations of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.20 EPS. As a group, analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on WBA shares. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their target price for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. StockNews.com began coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, May 13th. They issued a “hold” rating on the stock. Finally, Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.